Scotland’s life sciences sector champions revealed

The prestigious Scottish Enterprise Life Sciences Awards 2013 recognise the success and achievements of Scotland’s internationally renowned life sciences sector in areas including innovation, investment, community engagement and collaboration
Investment of the Year (2012) Award
Joint winners NuCana BioMed Limited, based in Edinburgh and GlaxoSmithKline, based in Irvine and Montrose
NuCana is in clinical studies with a new anti-cancer medicine that’s been developed using its ground-breaking, patented ProTide technology.
The company secured the largest equity financing into a life sciences company in Scotland in over five years with £7 million of inward investment from leading venture capital companies in Europe and America alongside investment from the Scottish Investment Bank and Alida Capital International.
GlaxoSmithKline is to invest £100 million across its two Scottish sites and create around new 100 jobs including 65 high value jobs.
The investment will be used to make the Irvine site a centre of excellence for the production of antibiotics, as well as backing the development of respiratory medicines and vaccines in Montrose and increasing the firm’s move to sustainable green energy production.